The global target for 2020 is that ≥90% of people living with HIV (PLHIV) receiving antiretroviral therapy (ART) will achieve viral load suppression (VLS). We examined VLS and its determinants among adults receiving ART for at least four months.
Prevalence of nonsuppressed viral load and associated factors among HIV‐positive adults receiving antiretroviral therapy in Eswatini, Lesotho, Malawi, Zambia and Zimbabwe (2015 to 2017): results from population‐based nationally representative surveys
A. Haas,E. Radin,Avi J. Hakim,A. Jahn,N. Philip,Sasi Jonnalagadda,S. Saito,A. Low,Hetal K Patel,Amee M. Schwitters,J. Rogers,K. Frederix,Evelyn Kim,G. Bello,Daniel B Williams,B. Parekh,Karampreet Sachathep,D. Barradas,T. Kalua,S. Birhanu,G. Musuka,O. Mugurungi,B. T. Tippett Barr,K. Sleeman,L. Mulenga,Kyaw Thin,T. Ao,Kristin Brown,A. Voetsch,J. Justman
Published 2020 in Journal of the International AIDS Society
ABSTRACT
PUBLICATION RECORD
- Publication year
2020
- Venue
Journal of the International AIDS Society
- Publication date
2020-11-01
- Fields of study
Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-44 of 44 references · Page 1 of 1
CITED BY
Showing 1-47 of 47 citing papers · Page 1 of 1